Patents by Inventor Marie-Luise Hagmann

Marie-Luise Hagmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein PDX1 as a marker for breast cancer
    Publication number: 20070196844
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein PDX1 (peroxiredoxin 1) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring PDX1 in said sample. Measurement of PDX1 can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Application
    Filed: December 14, 2006
    Publication date: August 23, 2007
    Inventors: Gabriele Pestlin, Herbert Andres, Marie-Luise Hagmann, Johann Karl, Michael Thierolf, Werner Zolg, Peter Berndt, Hanno Langen
  • Protein RS15A as a marker for colorectal cancer
    Publication number: 20070184498
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein RS15A (ribosomal protein S15a) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring RS15A in said sample. Measurement of RS15A can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: December 15, 2006
    Publication date: August 9, 2007
    Inventors: Michael Tacke, Marie-Luise Hagmann, Johann Karl, Michael Pfeffer, Herbert Andres, Michael Thierolf, Norbert Wild, Werner Zolg
  • Protein CBP2 as a marker for colorectal cancer
    Publication number: 20070161062
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein CBP2 (collagen-binding protein 2) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring CBP2 in said sample. Measurement of CBP2 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: December 15, 2006
    Publication date: July 12, 2007
    Inventors: Michael Tacke, Marie-Luise Hagmann, Johann Karl, Stefan Palme, Michael Pfeffer, Wolfgang Rollinger, Michael Thierolf, Werner Zolg
  • Nicotinamide N-methyltransferase as a marker for colorectal cancer
    Patent number: 7205118
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of the protein nicotinamide N-methyltransferase (NNMT) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: April 17, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Theresa Kott, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
  • Use of protein UBC13 as a marker for breast cancer
    Publication number: 20060257950
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of ubiquitin-conjugating enzyme E2N (UBC13) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring UBC13 in the sample. Measurement of UBC13 can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Application
    Filed: April 14, 2006
    Publication date: November 16, 2006
    Inventors: Gabriele Pestlin, Herbert Andres, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Werner Zolg
  • Use of protein spee as a marker for breast cancer
    Publication number: 20060257951
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of spermidine synthase (SPEE) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring SPEE in the sample. Measurement of SPEE can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Application
    Filed: April 14, 2006
    Publication date: November 16, 2006
    Inventors: Gabriele Pestlin, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Norbert Wild, Werner Zolg
  • Use of protein ASC as a marker for breast cancer
    Publication number: 20060257952
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein ASC in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring ASC in the sample. Measurement of ASC can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Application
    Filed: April 14, 2006
    Publication date: November 16, 2006
    Inventors: Gabriele Pestlin, Herbert Andres, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Werner Zolg
  • Use of protein PSE3 as a marker for colorectal cancer
    Publication number: 20060199232
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PSE3 (proteasome activator subunit 3) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PSE3 in said sample. Measurement of PSE3 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: February 7, 2006
    Publication date: September 7, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
  • Use of protein RLA-0 as a marker for colorectal cancer
    Publication number: 20060194266
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein RLA-0 (60S acidic ribosomal protein P0) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring RLA-0 in said sample. Measurement of RLA-0 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: February 7, 2006
    Publication date: August 31, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
  • Use of protein spee as a marker for colorectal cancer
    Publication number: 20060188950
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein SPEE (sperrnidine synthase) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring SPEE in said sample. Measurement of SPEE can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: February 7, 2006
    Publication date: August 24, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
  • Use of protein PLST as a marker for colorectal cancer
    Publication number: 20060188949
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PLST (T-plastin) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PLST in said sample. Measurement of PLST can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: February 7, 2006
    Publication date: August 24, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
  • Use of PRN3/ILEU as a marker for colorectal cancer
    Publication number: 20060177880
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PRN3/ILEU and/or unbound PRN3 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PRN3/ILEU and/or unbound PRN3 in said sample. Measurement of PRN3/ILEU and/or unbound PRN3 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: January 20, 2006
    Publication date: August 10, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg, Johann Karl
  • Cellular retinoic acid binding protein II as a marker for breast cancer
    Publication number: 20060141543
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein cellular retinoic acid binding protein II in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid binding protein II in said sample. Measurement of cellular retinoic acid binding protein II can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Application
    Filed: December 5, 2005
    Publication date: June 29, 2006
    Inventors: Gabriele Pestlin, Herbert Andres, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Werner Zolg
  • Use of protein MASP as a marker for colorectal cancer
    Publication number: 20060121540
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein MASP in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring MASP in said sample. Measurement of MASP can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: November 23, 2005
    Publication date: June 8, 2006
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
  • Nicotinamide N-methyltransferase as a marker for colorectal cancer
    Publication number: 20060003368
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of the protein nicotinamide N-methyltransferase (NNMT) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: June 14, 2005
    Publication date: January 5, 2006
    Inventors: Michael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Theresa Kott, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg